ArticleCancer research2019

Targeting the High-Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin.

Anirban Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.